Navigation Links
Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO
Date:5/29/2012

ults from the ENCORE clinical program provide the basis for moving entinostat into pivotal, phase 3 testing in metastatic breast complemented by biomarker driven confirmatory studies in lung cancer.

About Syndax

Syndax is a late-stage oncology company initiating pivotal programs in solid tumors based on employing epigenetic strategies to overcome the problem of resistance in oncology care. Syndax holds worldwide rights to entinostat, an oral, highly selective histone deacetylase (HDAC) inhibitor being developed in advanced breast and lung cancer. Randomized, placebo-controlled phase 2 studies with entinostat have demonstrated promising results in combination with aromatase inhibitors in breast cancer (ENCORE 301) and with the EGFR-TKI erlotinib (ENCORE 401) in non-small cell lung cancer providing the basis for moving entinostat into pivotal, phase 3 testing across a platform of solid tumor indications. NCI and Syndax are collaborating on the development of entinostat under a Cooperative Research and Development Agreement.

The company is supported by top venture capitalists and led by industry experts developing treatments for large markets including metastatic breast and lung cancer. Formed in 2005, Syndax's intellectual property is based on work from scientific founder Ronald Evans, Ph.D., recipient of the 2004 Albert Lasker Prize for Basic Medical Research, a Member of the National Academy of Sciences, a professor at the Salk Institute for Biological Studies and a Howard Hughes Medical Institute Investigator. For more information please visit www.syndax.com.

Syndax Contact Information
E. Blair Schoeb
Phone: 908.277.0386
Email: bschoeb@syndax.com


'/>"/>
SOURCE Syndax Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
2. Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
3. Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat
4. Syndax Pharmaceuticals Entinostat Plus Erlotinib Improves Survival in Select NSCLC Patients
5. Syndax Pharmaceuticals Entinostat in Combination Shows Activity in Breast Cancer
6. Syndax Pharmaceuticals to Present at Biotech Showcase 2011
7. Syndax Announces Publication of Entinostat NSCLC Data in Cancer Research
8. Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer
9. Syndax Pharmaceuticals Announces Entinostat Data at 102nd Annual American Association for Cancer Research Meeting
10. Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat
11. Syndax Pharmaceuticals Elects Arlene Morris to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  Breg, Inc., a premier provider ... the FreeRunner™ knee brace with new innovations to ... mal-tracking return to active lifestyles.  FreeRunner,s patent-pending design ... providing support when patients need it most, and ... Patellofemoral issues are the most common ...
(Date:7/10/2014)... LAVAL, Quebec , July 10, 2014  Valeant ... TSX: VRX) today announced it has completed the sale ... Sculptra, and Dysport owned or held by Valeant for ... agreement with Nestle S.A, which recently completed its acquisition ... complete the divestiture of our products to a company ...
(Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
(Date:7/11/2014)... 2014 Recently, iFitDress.com, a leading online ... has released its new collection of evening dresses ... has announced that all these beautiful items are provided ... of the special offer is July 22. , ... pay close attention to customer satisfaction. On the company’s ...
(Date:7/11/2014)... H.E.A.R Me Out Listens to Needs ... week to provide comprehensive information and services available to ... million Coloradoans with hearing loss, this organization is the ... of the local and state resources that aims to ... , H.E.A.R. Me Out and its website was founded ...
(Date:7/11/2014)... Los Angeles dental implant expert ... and full mouth implants to replace missing teeth. Both ... dental implants from other tooth replacements: They replace the ... alone prevents the long-term complications of missing teeth, but ... comfort, appearance and systemic health. Mini implants broaden candidacy ...
(Date:7/11/2014)... 2014 Having experienced mental illness from the ... mental hospital staff, Roger Grainger gives readers an intimate look ... new book, “You Never Get Out.” , According to the ... Kingdom will experience some kind of mental health problem in ... to take a look at the way mental illness is ...
(Date:7/11/2014)... HealthDay Reporter FRIDAY, July 11, ... who can,t cough, sneeze or laugh without losing bladder ... cells to regenerate weakened urethra muscles. In a ... cells isolated from patients, own fat tissue improved or ... Stress incontinence affects about twice as many ...
Breaking Medicine News(10 mins):Health News:Worldwide Chic Ladies Can Buy Cheap Evening Dresses at iFitDress.com 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 3Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:Psychiatric Hospital Patient and Registered Psychologist Explores Mental Health and Therapy in New Book "You Never Get Out" 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3
... bedside patient safety solutions -SAN DIEGO, April 3 ... handheld barcode point-of-care (BPOC) solutions ... Sweeney has been appointed Chairman and CEO.(Logo: ... CEO of eight healthcare service companies including Bridge ...
... boost strength in other ways, researchers say , , FRIDAY, April ... mass in octogenarian women but still helped them lift more ... University in Indiana finds. , , The six ... for three months on a machine designed to strengthen the ...
... F C, s * ... , Although recent media attention has focused on the presence of ... Protection Agency and the U.S. Food and Drug Administration (FDA) have ... appropriate for all consumers, including sensitive sub-populations like infants. Trace ...
... Inc. (Nasdaq: MEDQ ) has announced it has ... of Sales and Marketing. Gold will be responsible for ... of MedQuist. "We are pleased to have Alan join the ... brings an extensive knowledge and an in-depth understanding of healthcare ...
... poorer scores on cognitive tests , , FRIDAY, April 3 (HealthDay News) ... life span may be taking a toll on the brains of ... shows that women aged 47 to 74 who tested positive for ... or bones (an indication of cumulative exposure over the life span) ...
... & Spa,Group, Inc. (OTC Bulletin Board: SOKF) announced the ... April 1, 2009. The latest SOKO Spa began,offering "pre-opening" ... more,than 500 Spa members since that date. , ... Blessing Hot Spring Business Club,No.332, Xinyang Rd., Daoli District, ...
Cached Medicine News:Health News:James M. Sweeney Named Chairman and CEO of IntelliDOT 2Health News:James M. Sweeney Named Chairman and CEO of IntelliDOT 3Health News:James M. Sweeney Named Chairman and CEO of IntelliDOT 4Health News:Muscle Mass Won't Grow in Women Over 80 2Health News:International Formula Council (IFC) Reassures Parents about Perchlorate and the Safety of Infant Formula 2Health News:MedQuist Names Alan J. Gold as Senior Vice President, Sales and Marketing 2Health News:Accumulated Lead May Affect Older Women's Brains 2Health News:SOKO Fitness & Spa Group, Inc. Opens Xinyang Spa in Harbin 2
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: